查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451268

2024-2032 年他汀類藥物市場報告（按類型、治療領域、藥物類別、應用、分佈和地區）

Statin Market Report by Type, Therapeutic Area, Drug Class, Application, Distribution, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2023年全球他汀類藥物市場規模達154億美元。展望未來， IMARC Group預計到2032年市場規模將達到200億美元，2024-2032年複合年成長率（CAGR）為2.9%。由於全球心血管疾病和高膽固醇血症的盛行率不斷上升、醫療基礎設施的擴大以及降膽固醇藥物保險範圍的擴大，刺激了全球需求，該市場正在經歷穩定成長。

他汀類藥物市場分析：

市場成長與規模：全球市場正在經歷顯著成長，這主要是由於心血管疾病盛行率的不斷上升所推動的。隨著降膽固醇藥物需求的不斷成長，市場規模不斷擴大，反映出人們對管理心臟健康的有效治療方法的認知和需求不斷增強。

技術進步：技術發展，特別是在個人化醫療領域，正在徹底改變他汀類藥物市場。基因組學和生物資訊學的進步使更個人化的治療方法成為可能，提高了他汀類藥物的療效並降低了不良反應的風險，從而推動了市場成長。

產業應用：他汀類藥物主要用於醫療保健產業，透過降低低密度脂蛋白膽固醇水平來預防和治療心血管疾病。它們的應用已成為管理心臟健康不可或缺的一部分，特別是在心臟病高風險族群。

主要市場趨勢：他汀類藥物市場的一個顯著趨勢是向精準醫療的轉變，即根據個別基因譜量身訂做治療方法。此外，人們越來越關注預防性醫療保健措施，這推動了對他汀類藥物作為心血管疾病預防藥物的需求。

地理趨勢：在人口老化和生活方式相關心臟病風險因素普遍存在的地區，對他汀類藥物的需求尤其高。北美和歐洲等已開發地區目前主導市場，但由於健康意識的提高和醫療基礎設施的改善，新興經濟體的需求不斷成長。

競爭格局：全球市場的特徵是存在多個關鍵參與者，競爭由創新、產品開發和行銷策略驅動。市場也見證了製藥公司和醫療保健提供者之間的合作，以提高他汀類藥物治療的可及性和有效性。

挑戰與機會：市場的一項主要挑戰是解決與他汀類藥物使用相關的不良反應，這可能會影響患者的依從性。然而，這項挑戰為開發副作用較少的新他汀類藥物製劑提供了機會。此外，全球心血管疾病發生率的增加為市場擴張提供了巨大的機會。

他汀類藥物市場趨勢：

心血管疾病盛行率增加

心血管疾病（CVD）發生率的上升主要推動了全球市場的發展。他汀類藥物以其降低膽固醇的特性而聞名，在心血管疾病的管理和預防中發揮關鍵作用。這種日益嚴重的健康負擔導致人們對高低密度脂蛋白膽固醇等危險因子的認知不斷增強並積極主動地進行管理。因此，這對市場有正面影響。因此，由於患者數量的增加和對預防性醫療保健的日益重視，對他汀類藥物的需求不斷增加。這種趨勢在人口老化和生活方式相關危險因子的地區尤其明顯，使他汀類藥物成為心血管健康治療和管理的關鍵組成部分。

個人化醫療的進步

個人化醫療的重大進步也推動了全球市場的發展。個人化或精準醫學涉及根據每位患者的個別特徵制定醫療治療方案，就他汀類藥物而言，這涉及考慮影響個人對這些藥物反應的遺傳因素。此外，研究表明，遺傳變異會影響一個人對他汀類藥物的反應，無論是在療效還是副作用風險方面。因此，人們越來越關注開發最佳化他汀類藥物治療的個人化治療計劃。此外，基因組學和生物資訊學在醫療保健領域的整合是推動市場創新和成長的關鍵因素。

政府措施和醫療保健政策

政府措施和醫療保健政策對全球市場產生重大影響。世界各地許多政府正在實施政策和計劃來應對不斷上升的心臟病發病率。這些措施通常包括膽固醇管理指南，建議使用他汀類藥物作為第一線治療。此外，政府和醫療機構越來越關注預防性醫療措施，並認知到預防心臟病而不是事後治療的成本效益。這種焦點的轉變導致公共衛生活動的資金增加，提高了人們對膽固醇管理重要性的認知，從而推動了對他汀類藥物的需求。此外，他汀類藥物涵蓋國家和國際治療指南進一步強調了其在心血管健康管理中的重要性，並促進了其在臨床實踐中的採用。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球他汀類藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 合成他汀類藥物
    • 市場走向
    • 市場預測
  • 天然他汀類藥物
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依治療領域

  • 心血管疾病
    • 市場走向
    • 市場預測
  • 肥胖
    • 市場走向
    • 市場預測
  • 發炎性疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依藥物類別

  • 阿托伐他汀
    • 市場走向
    • 市場預測
  • 氟伐他汀
    • 市場走向
    • 市場預測
  • 洛伐他汀
    • 市場走向
    • 市場預測
  • 普伐他汀
    • 市場走向
    • 市場預測
  • 辛伐他汀
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按應用

  • 血脂異常
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：依分佈

  • 醫院
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格指標

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott
    • AstraZeneca
    • Aurobindo Pharma
    • Biocon
    • GlaxoSmithKline
    • Merck & Co.
    • Novartis
    • Pfizer
Product Code: SR112024A1885

The global statin market size reached US$ 15.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The market is experiencing steady growth driven by the increasing prevalence of cardiovascular diseases and hypercholesterolemia globally, the expanding healthcare infrastructure and the availability of insurance coverage for cholesterol-lowering medications bolster demand across the globe.

Statin Market Analysis:

Market Growth and Size: The global market is experiencing significant growth, driven largely by the increasing prevalence of cardiovascular diseases. With the rising demand for cholesterol-lowering drugs, the market size is expanding, reflecting a growing awareness and need for effective treatments in managing heart health.

Technological Advancements: Technological developments, particularly in the field of personalized medicine, are revolutionizing the statin market. Advances in genomics and bioinformatics are enabling more personalized treatment approaches, improving the efficacy of statins and reducing the risk of adverse effects, thus propelling market growth.

Industry Applications: Statins are primarily used in the healthcare industry for the prevention and treatment of cardiovascular diseases by lowering LDL cholesterol levels. Their application has become integral in managing heart health, especially in populations with high risk of heart diseases.

Key Market Trends: A notable trend in the statin market is the shift towards precision medicine, where treatments are tailored to individual genetic profiles. Additionally, there is an increasing focus on preventive healthcare measures, which is driving the demand for statins as a preventive medication for cardiovascular diseases.

Geographical Trends: The demand for statins is particularly high in regions with aging populations and those with prevalent lifestyle-related risk factors for heart diseases. Developed regions such as North America and Europe currently dominate the market, but there is a growing demand in emerging economies due to increasing health awareness and improving healthcare infrastructure.

Competitive Landscape: The global market is characterized by the presence of several key players, with competition driven by innovation, product development, and marketing strategies. The market is also witnessing collaborations between pharmaceutical companies and healthcare providers to enhance the accessibility and effectiveness of statin therapy.

Challenges and Opportunities: One major challenge in the market is addressing the adverse effects associated with statin use, which can affect patient compliance. However, this challenge presents an opportunity for the development of new statin formulations with fewer side effects. Additionally, the increasing incidence of cardiovascular diseases globally offers a substantial opportunity for market expansion.

Statin Market Trends:

Increasing prevalence of cardiovascular diseases

The rising incidence of cardiovascular diseases (CVDs) majorly drives the global market. Statins, known for their cholesterol-lowering properties, play a critical role in the management and prevention of CVDs. This growing health burden is leading to a growing awareness and proactive management of risk factors such as high LDL cholesterol. Therefore, this is positively influencing the market. Consequently, the demand for statins is escalating, driven by both the increasing number of patients and the growing emphasis on preventive healthcare. This trend is particularly noticeable in regions with aging populations and lifestyle-related risk factors, making statins a key component in the treatment and management of cardiovascular health.

Advancements in personalized medicine

The global market is also being propelled forward by significant advancements in personalized medicine. Personalized, or precision, medicine involves tailoring medical treatment to the individual characteristics of each patient, and in the case of statins, this involves considering genetic factors that affect an individual's response to these drugs. Additionally, research has shown that genetic variations can influence a person's response to statins, both in terms of efficacy and risk of side effects. As a result, there is an increasing focus on developing personalized treatment plans that optimize statin therapy. In addition, the integration of genomics and bioinformatics in healthcare is thus a key factor driving innovation and growth in the market.

Government initiatives and healthcare policies

Government initiatives and healthcare policies significantly influence the global market. Many governments across the world are implementing policies and programs to combat the rising incidence of heart disease. These initiatives often include guidelines for cholesterol management, which recommend the use of statins as a first-line therapy. Moreover, governments and healthcare organizations are increasingly focusing on preventive healthcare measures, recognizing the cost-effectiveness of preventing heart diseases rather than treating them post-occurrence. This shift in focus is leading to increased funding for public health campaigns that raise awareness about the importance of cholesterol management, thereby driving the demand for statins. Additionally, the inclusion of statins in national and international treatment guidelines further underscores their importance in cardiovascular health management and boosts their adoption in clinical practice.

Statin Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, therapeutic area, drug class, application, and distribution.

Breakup by Type:

Synthetic Statins

Natural Statins

Natural statins account for the majority of the market share

The report has provided a detailed breakup and analysis of the statin market based on the type. This includes synthetic statins and natural statins. According to the report, natural statins represented the largest segment.

Breakup by Therapeutic Area:

Cardiovascular Disorders

Obesity

Inflammatory Disorders

Others

A detailed breakup and analysis of the statin market based on the therapeutic area has also been provided in the report. This includes cardiovascular disorders, obesity, inflammatory disorders, and others.

Breakup by Drug Class:

Atorvastatin

Fluvastatin

Lovastatin

Pravastatin

Simvastatin

Others

Atorvastatin represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, and others. According to the report, atorvastatin accounted for the largest market share.

Breakup by Application:

Dyslipidemia

Others

A detailed breakup and analysis of the statin market based on the application has also been provided in the report. This includes dyslipidemia and others.

Breakup by Distribution:

Hospitals

Clinics

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the distribution. This includes hospitals, clinics, and others. According to the report, hospitals accounted for the largest market share.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest statin market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AstraZeneca

Aurobindo Pharma

Biocon

GlaxoSmithKline

Merck & Co.

Novartis

Pfizer

Key Questions Answered in This Report

  • 1. What was the size of the global statin market in 2023?
  • 2. What is the expected growth rate of the global statin market during 2024-2032?
  • 3. What are the key factors driving the global statin market?
  • 4. What has been the impact of COVID-19 on the global statin market?
  • 5. What is the breakup of the global statin market based on the type?
  • 6. What is the breakup of the global statin market based on the drug class?
  • 7. What is the breakup of the global statin market based on the distribution?
  • 8. What are the key regions in the global statin market?
  • 9. Who are the key players/companies in the global statin market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Statin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Synthetic Statins
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Natural Statins
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Cardiovascular Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obesity
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inflammatory Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Atorvastatin
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fluvastatin
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lovastatin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pravastatin
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Simvastatin
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Dyslipidemia
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Others
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Distribution

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Italy
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Spain
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Russia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 Japan
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 India
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Indonesia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 AstraZeneca
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Aurobindo Pharma
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Biocon
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 GlaxoSmithKline
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Merck & Co.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Novartis
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Pfizer
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Statin Market: Major Drivers and Challenges
  • Figure 2: Global: Statin Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Statin Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Statin Market: Breakup by Therapeutic Area (in %), 2023
  • Figure 5: Global: Statin Market: Breakup by Drug Class (in %), 2023
  • Figure 6: Global: Statin Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Statin Market: Breakup by Distribution (in %), 2023
  • Figure 8: Global: Statin Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Statin Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Statin (Synthetic Statins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Statin (Synthetic Statins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Statin (Natural Statins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Statin (Natural Statins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Statin (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Statin (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Statin (Obesity) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Statin (Obesity) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Statin (Inflammatory disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Statin (Inflammatory disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Statin (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Statin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Statin (Atorvastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Statin (Atorvastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Statin (Fluvastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Statin (Fluvastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Statin (Lovastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Statin (Lovastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Statin (Pravastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Statin (Pravastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Statin (Simvastatin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Statin (Simvastatin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Statin (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Statin (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Statin (Dyslipidemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Statin (Dyslipidemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Statin (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Statin (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Statin (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Statin (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Statin (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Statin (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Statin (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Statin (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: North America: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: North America: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: United States: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: United States: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Canada: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Canada: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia Pacific: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia Pacific: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: China: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: China: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Japan: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Japan: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: India: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: India: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: South Korea: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: South Korea: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Australia: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Australia: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Indonesia: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Indonesia: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Europe: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Europe: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Germany: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Germany: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: France: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: France: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: United Kingdom: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: United Kingdom: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Italy: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Italy: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Spain: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Spain: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Russia: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Russia: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Latin America: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Latin America: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Brazil: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Brazil: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Mexico: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Mexico: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Middle East and Africa: Statin Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Middle East and Africa: Statin Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Global: Statin Industry: SWOT Analysis
  • Figure 93: Global: Statin Industry: Value Chain Analysis
  • Figure 94: Global: Statin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Statin Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Statin Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Statin Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
  • Table 4: Global: Statin Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 5: Global: Statin Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Statin Market Forecast: Breakup by Distribution (in Million US$), 2024-2032
  • Table 7: Global: Statin Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Statin Market: Competitive Structure
  • Table 9: Global: Statin Market: Key Players